Cancer Types & Treatments
NCI CANCER CENTER
Patients & Caregivers
Becoming Our Patient
Cancer Education
Tools & Resources
For Caregivers
Support Services
Survivorship & Hope
Clinical Trials
Find a Clinical Trial
Reasons to Participate
How to Join a Clinical Trial
For Professionals & Partners
Research
Areas of Research
Find a Researcher
Shared Resources and Core Facilities
Research Programs
Membership & Grants
Research That Transforms
Give Back to Research
Training & Education
Faculty Development
Graduate Education
Fellowship & Residency
High School & Undergraduate
Outreach & Prevention
Outreach & Community Initiatives
Prevention & Risk Reduction
Cancer Awareness
In recognition of the upcoming Thanksgiving holiday, many of The University of Cancer Center's offices will have modified hours during this time.
TEAMSPORT will create a standardized approach to ordering genomic tests and adapt it for use in community cancer centers, where most cancer patients receive testing and treatment.
The University of Kansas Cancer Center lymphedema program was recently named a Comprehensive Center of Excellence in the diagnosis and treatment of lymphatic disease.
Megha Ramaswamy, PhD, MPH, will serve as Associate Director for Cancer Workforce Equity.
The University of Kansas Cancer Center announced its 2022 recipients of the Director’s Awards, which recognizes individuals who have made significant contributions to the cancer center’s mission, and Pilot Awards, which funds promising novel research being conducted by cancer center members.
Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer
Clinicians and researchers recently received recognition for clinical trial accruals through the National Cancer Institute’s (NCI) National Community Oncology Research Program (NCORP).
Experimental Therapeutics Clinical Trials Network (ETCTN) membership will increase the number of early-stage clinical trials KU Cancer Center can offer to people with cancer.
The cancer center is one of just 53 centers in the country to be awarded Comprehensive status from the NCI.
The five-year grant will fund research studying a protein associated with the development of cancer and other diseases.
KU Cancer Center researchers contributed to Beat AML study
KU Cancer Center has been designated as a “Comprehensive” cancer center by the NCI, the highest level of recognition awarded and the gold standard for cancer centers.
African Americans have disproportionately high rates of tobacco-related disease, making treatment critical.
Jamie Wagner, DO, FACOS, FACS, division chief, breast surgical oncology, has been named Surgical Vice Chair of the Breast Committee for the Alliance for Clinical Trials in Oncology.